Published: May 27, 2026 · Last updated: May 27, 2026
- Cirrhosis often progresses silently for years; up to a third of adults with cirrhosis are diagnosed only after a hospital admission for a complication like bleeding or fluid buildup (NIH NIDDK, 2024)
- Liver enzymes (ALT, AST) can be entirely normal in compensated cirrhosis, which is why physicians use scoring tools and imaging rather than relying on enzymes alone (Mayo Clinic, 2024)
- The two largest drivers of advanced liver disease in the U.S. are alcohol intake and metabolic dysfunction (MASLD/MASH), and many people carry both quietly into their 50s and 60s (Cleveland Clinic, 2024)
The liver is unusual among organs. It can lose roughly half of its functional mass before producing real symptoms. By the time fatigue, jaundice, or fluid retention shows up, the disease is usually well advanced.
That biology is why advanced liver disease so often arrives as a surprise. The good news is that the diagnostic and screening tools have improved sharply, and early-stage liver disease is far easier to reverse than late-stage. The catch: nobody is going to discover it for you unless you ask.
Why the Liver Stays Quiet So Long
Built for Redundancy: The liver has a large reserve capacity and the ability to regenerate. Hepatologists describe this as "compensated" disease: the organ is sick, but the remaining healthy tissue still does the metabolic work the body needs (NIH NIDDK, 2024).
People in this phase generally feel fine. Energy is normal. Routine bloodwork can look normal. The first real symptoms (yellowing of the skin or eyes, swelling in the legs or abdomen, mental fog, bruising from minor bumps) only appear in "decompensated" disease, often years later.
This is the diagnostic gap. By the time the liver "complains" loudly enough for a primary-care visit to catch it, the disease has often progressed past the easy-to-reverse stage. The fix is not to wait for symptoms; it is to screen earlier.
Why Enzymes Can Lie
The Limits of ALT and AST: A standard liver panel measures enzymes released by damaged liver cells. In acute injury, those numbers spike. In chronic, slow-burn fibrosis, they can sit in the normal range even as scarring progresses. Up to 20 to 30 percent of adults with significant fibrosis have normal ALT (Mayo Clinic, 2024).
This is why hepatologists no longer rely on enzymes alone. The FIB-4 score combines age, AST, ALT, and platelets to estimate fibrosis risk. An elevated FIB-4 in a person with normal enzymes is a real signal worth investigating.
A second non-invasive tool, FibroScan, uses an ultrasound-based probe to estimate liver stiffness, which correlates with fibrosis. It is widely available now in gastroenterology offices and takes about 10 minutes. Many adults at risk have never been offered it.
The Two Engines of Advanced Liver Disease
Alcohol and Metabolism: Alcohol-related liver disease and metabolic dysfunction-associated steatotic liver disease (MASLD) are the two biggest contributors in the U.S. Both can progress to cirrhosis through years of quiet inflammation and scarring (Cleveland Clinic, 2024).
A pattern hepatologists see often: a moderate drinker (1 to 2 drinks a day for 20 years), modest belly weight gain, mild prediabetes, mild hypertension. Each risk factor on its own looks small. Stacked, they double or triple the liver disease risk and accelerate fibrosis.
This is the audience the early-detection conversation is for. Not heavy drinkers in obvious crisis. The "I'm basically fine" group whose labs are mostly normal and whose habits have not changed in 15 years.
Viral hepatitis B and C remain meaningful contributors as well, particularly in adults born between 1945 and 1965 who may have undiagnosed hepatitis C from old transfusions or other exposures. A one-time screening for both is part of standard preventive care for that age band.
What Screening Actually Looks Like
Three Layers, Cheap to Expensive: Layer 1: a standard liver panel plus platelets and an A1C, then the FIB-4 score. Costs almost nothing if labs are already drawn. Layer 2: an abdominal ultrasound to look for fatty liver. Layer 3: FibroScan or MRI elastography to estimate fibrosis stage without a biopsy.
If you are over 40 and carry any combination of BMI over 27, prediabetes, type 2 diabetes, high triglycerides, or moderate alcohol intake, asking for FIB-4 plus a discussion of imaging is reasonable. If you are at higher risk, the conversation gets more directive.
What Reverses, What Does Not
Early Beats Late: Hepatic steatosis (simple fat in the liver) is widely reversible with weight loss of 7 to 10 percent of body weight and sustained reduction in alcohol and sugar intake. Mild fibrosis often regresses with the same lifestyle changes. Once cirrhosis is established, reversal becomes much harder and the goal shifts to stabilizing the disease and avoiding complications.
The window for cheap, lifestyle-only reversal is wider than most people realize, but only if the problem is caught while symptoms are still absent. After the first "something is wrong" moment, the runway shrinks.
To your health,
Ageless Coach
Age Strong. Live Long.
Trusted Sources Behind This Article
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reading this article does not create a provider-patient relationship. Always consult your physician or qualified healthcare provider before making changes to your diet, exercise, or health routine. Ageless Coach is not liable for any actions taken based on this information.
Frequently Asked Questions
Want one verified-science article like this every week?
Get Better Health, Weekly